A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Pāmu narrows profit forecast, expects record year
Primary Sector

Pāmu narrows profit forecast, expects record year

Its record year was foreshadowed last month. 

Riley Kennedy 24 Jul 2025
Beefed-up tariffs on Brazil no threat to NZ’s pricing
Primary Sector

Beefed-up tariffs on Brazil no threat to NZ’s pricing

NZ is a high-value premium producer of beef, as opposed to Brazil.

Riley Kennedy 24 Jul 2025
Northland targets $60b regional economy by 2050
Primary Sector

Northland targets $60b regional economy by 2050

The bullish goal represents a six-fold increase over 2024 figures.

Oliver Lewis 24 Jul 2025
Global meat demand surges, but NZ’s supply is lagging
Primary Sector

Global meat demand surges, but NZ’s supply is lagging

It could be costing NZ hundreds of millions of dollars in lost export revenue.

Riley Kennedy 23 Jul 2025